State Medicaid director letter · Nov 13, 2026
CMS offers an optional Medicaid transition period
States still have to assess compliance and exemptions starting by Jan 1, 2027. With CMS approval, states can suspend denials and disenrollments tied to the requirement through June 30, 2027. States seeking to start the option Jan 1 are asked to notify CMS by Dec 11.
CMS letter · Medical exemption ruling
Final rule issued Nov 5 · Effective Dec 5, 2026
Medicare codifies its drug negotiation process
The final rule puts policies for negotiating and applying prices into regulation for prices effective in 2029 and later. Earlier negotiation cycles follow their own schedules.
CMS fact sheet
Final rules announced · Oct 5, 2026
Agencies update health-plan price disclosures
HHS, Labor, and Treasury finalized changes to the Transparency in Coverage rules. They update what plans and issuers must disclose and how the data are published for use by patients, employers, and researchers.
CMS fact sheet
Final rule published Oct 2 · Effective Nov 30, 2026
Medicare tests international drug-price benchmarks
The GLOBE model uses prices in other countries to calculate rebates for certain Part B drugs in the test. The performance period starts in April 2027. A federal lawsuit challenges the rule.
Federal Register · Pending challenge